Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfizer, Teva Settle Drug Patent Litigation | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pfizer, Teva Settle Drug Patent Litigation

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfizer and Teva Pharmaceutical Industries have settled a patent litigation regarding Teva’s sale of generic versions of Pfizer’s Zithromax antibiotic and Idamycin cancer drug. Under the agreement, Teva will pay Pfizer as much as $70 million and will continue to market its generic versions of the two drugs. The settlement also includes an option for Teva to sell its generic version of another cancer drug, epirubicin, prior to the August 2007 patent expiration, according to a Pfizer statement.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters